can semaglutide cause bladder issues Beyond Glycemic Control: Concurrent GLP-1 Receptor Agonist Use Is Associated with Reduced Urinary Adverse Events Following OnabotulinumtoxinA Treatment in Non-Diabetic Adults with Overactive What are the long-term side

Its effect on pregnancy is not clear, but an increased risk of miscarriage has been reported

[DOI] [PMC free article] [PubMed] [Google Scholar] 84

FDA approves Boehringer Ingelheim's Nerandomilast, an oral PDE4B inhibitor for idiopathic pulmonary fibrosis treatment, marking the first new drug approved for the disease in over a decade To view or add a comment, sign in "It's an exciting time for biologics." We had a classic late Friday #FDA approval this week: Tezepelumab (Tezspire) received indication to treat adults and children 12 years old with chronic rhinosinutis with nasal polyps the 4th biologic approved for CRSwNP, but the first to target the TSLP pathway

Drug Class 92 18.1.1

The treatment algorithm recommends a patient centered and individualized treatment approach with the goal to prevent diabetes-related complications and to optimize quality of life in patients with type 2 diabetes